litlas
Log inCreate account

Robert W. Shafer

Active 1984–2025

Also published as
Robert W Shafer
142
Papers
22,647
Citations
88
h-index
136
i10-index

Citations

Citations per year for Robert W. Shafer1984: 2 citations1991: 4 citations1992: 7 citations1993: 16 citations1994: 13 citations1995: 33 citations1996: 40 citations1997: 32 citations1998: 51 citations1999: 65 citations2000: 68 citations2001: 56 citations2002: 66 citations2003: 81 citations2004: 128 citations2005: 120 citations2006: 148 citations2007: 119 citations2008: 188 citations2009: 180 citations2010: 190 citations2011: 212 citations2012: 180 citations2013: 173 citations2014: 118 citations2015: 136 citations2016: 137 citations2017: 76 citations2018: 106 citations2019: 414 citations2020: 325 citations2021: 353 citations2022: 532 citations2023: 299 citations2024: 454 citations2025: 235 citations2026: 14 citations1985–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,902 citing papers, 27.5% of this breakdownUnited Kingdom: 513 citing papers, 7.4% of this breakdownChina: 309 citing papers, 4.5% of this breakdownSouth Africa: 259 citing papers, 3.7% of this breakdownGermany: 256 citing papers, 3.7% of this breakdownFrance: 250 citing papers, 3.6% of this breakdownCanada: 221 citing papers, 3.2% of this breakdownItaly: 219 citing papers, 3.2% of this breakdownSpain: 203 citing papers, 2.9% of this breakdownSwitzerland: 202 citing papers, 2.9% of this breakdownNetherlands: 169 citing papers, 2.4% of this breakdownBelgium: 136 citing papers, 2% of this breakdown
0%27.5%Other 33%

Institutions

Fields

  • Medicine65%
  • Immunology and Microbiology15.4%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Computer Science3.2%
  • Agricultural and Biological Sciences1.9%
  • Mathematics1%
  • Other3.3%

Topics

  • HIV Research and Treatment14.4%
  • HIV/AIDS drug development and treatment14.3%
  • HIV/AIDS Research and Interventions9%
  • SARS-CoV-2 and COVID-19 Research4.6%
  • HIV-related health complications and treatments3.4%
  • COVID-19 Clinical Research Studies2.4%
  • Other51.9%

Coauthors

All papers

Open in search
  1. The biological and clinical significance of emerging SARS-CoV-2 variants

    Authors: Kaiming Tao, Philip L. Tzou, Janin Nouhin, Ravindra K. Gupta, Túlio de Oliveira, Sergei L. Kosakovsky Pond, Daniela Fera, Robert W. Shafer - Nature Reviews Genetics 2021 cited by 1,108

  2. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic

    Authors: Hector Bonilla, Tom Quach, Anushri Tiwari, Andres Bonilla, Mitchell G. Miglis, Phillip Yang, L. Eggert, Husham Sharifi, Audra Horomanski, Aruna Subramanian, Liza Smirnoff, Norah Simpson, Houssan Halawi, Oliver Sum‐Ping, Agnieszka Kalinowski, Zara M. Patel, Robert W. Shafer, Linda N. Geng - Frontiers in Neurology 2023 cited by 130

  3. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)

    Authors: Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, Lindsey R. Baden, Vincent Chi‐Chung Cheng, Kathryn M. Edwards, Jason C Gallagher, Rajesh T. Gandhi, William J. Muller, Mari Nakamura, John C. O’Horo, Robert W. Shafer, Shmuel Shoham, M. Hassan Murad, Reem A. Mustafa, Shahnaz Sultan, Yngve Falck–Ytter - Clinical Infectious Diseases 2022 cited by 201

  4. Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection

    Authors: Linda N. Geng, Hector Bonilla, Haley Hedlin, Karen B. Jacobson, Lü Tian, Prasanna Jagannathan, Phillip C. Yang, Aruna Subramanian, Jane W. Liang, Sa Shen, Yaowei Deng, Blake Shaw, Bren Botzheim, Manisha S. Desai, Divya Pathak, Yasmin Jazayeri, Daniel Thai, Andrew O’Donnell, Sukanya Mohaptra, Zenita Leang, Gabriella Z. M. Reynolds, Erin F. Brooks, Ami S. Bhatt, Robert W. Shafer, Mitchell G. Miglis, Tom Quach, Anushri Tiwari, Anindita Banerjee, Rene N. Lopez, Magdia De Jesus, Lawrence Charnas, Paul J. Utz, Upinder Singh - JAMA Internal Medicine 2024 cited by 106

  5. 2015 update of the drug resistance mutations in HIV-1

    Authors: Annemarie M. J. Wensing, Vincent Cálvez, Günthard, Huldrych F, Johnson, Victoria A, Huldrych F. Günthard, Roger Paredes, Robert W. Shafer, Douglas D. Richman - 2015 cited by 361

  6. Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation

    Authors: T. F. Liu, Robert W. Shafer - Clinical Infectious Diseases 2006 cited by 672

  7. HIV-1 drug resistance and resistance testing

    Authors: Dana Clutter, Michael R. Jordan, Silvia Bertagnolio, Robert W. Shafer - Infection Genetics and Evolution 2016 cited by 335

  8. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

    Authors: Jennifer Smith, Loveleen Bansi‐Matharu, Valentina Cambiano, Dobromir Dimitrov, Anna Bershteyn, David van de Vijver, Katharine Kripke, Paul Revill, Marie‐Claude Boily, Gesine Meyer‐Rath, Isaac Taramusi, Jens Lundgren, Joep J. van Oosterhout, Daniel R. Kuritzkes, Robin Schaefer, Mark J. Siedner, Jonathan Schapiro, Sinéad Delany‐Moretlwe, Raphael J. Landovitz, Charles Flexner, Michael R. Jordan, François Venter, Mopo Radebe, David H. Brown Ripin, Sarah M. Jenkins, Danielle Resar, Carolyn Amole, Maryam Shahmanesh, Ravindra K. Gupta, Elliot Raizes, Cheryl Johnson, Seth Inzaule, Robert W. Shafer, Mitchell Warren, Sarah E. Stansfield, Roger Paredes, Andrew Phillips - The Lancet HIV 2023 cited by 64

  9. Rationale and Uses of a Public HIV Drug‐Resistance Database

    Authors: Robert W. Shafer - The Journal of Infectious Diseases 2006 cited by 428

  10. Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons

    Authors: Philip L. Tzou, Kaiming Tao, Sergei L. Kosakovsky Pond, Robert W. Shafer - PLoS ONE 2022 cited by 122

  11. SARS-CoV-2 Antiviral Therapy

    Authors: Kaiming Tao, Philip L. Tzou, Janin Nouhin, Hector Bonilla, Prasanna Jagannathan, Robert W. Shafer - Clinical Microbiology Reviews 2021 cited by 99

  12. Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database

    Authors: Robert W. Shafer, Derek Stevenson, Bryan Chan - Nucleic Acids Research, Nucleic Acids Res. 1999 cited by 932

  13. Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations

    Authors: Santiago Ávila‐Ríos, Neil Parkin, Ronald Swanstrom, Roger Paredes, Robert W. Shafer, Hezhao Ji, Rami Kantor - Viruses 2020 cited by 87

  14. 2017 Update of the Drug Resistance Mutations in HIV-1.

    Authors: Annemarie M. J. Wensing, Vincent Cálvez, Huldrych F. Günthard, Victoria A. Johnson, Roger Paredes, Deenan Pillay, Robert W. Shafer, Douglas D. Richman - 2016 cited by 165

  15. Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance

    Authors: Philip L. Tzou, Soo‐Yon Rhee, Diane Descamps, Dana Clutter, Bradley Hare, Orna Mor, Maxime Grudé, Neil Parkin, Michael R. Jordan, Silvia Bertagnolio, Jonathan Schapiro, P. Richard Harrigan, Anna María Geretti, Anne‐Geneviève Marcelin, Robert W. Shafer, on behalf of the WHO HIVResNet Working Groups - Journal of Antimicrobial Chemotherapy 2019 cited by 89

  16. A systematic review of the genetic mechanisms of dolutegravir resistance

    Authors: Soo‐Yon Rhee, Philip Grant, Philip L. Tzou, Geoffrey Barrow, P. Richard Harrigan, John P. A. Ioannidis, Robert W. Shafer - Journal of Antimicrobial Chemotherapy 2019 cited by 153

  17. Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review

    Authors: Carolyn Chu, Kaiming Tao, Vinie Kouamou, Ava Avalos, Jake Scott, Philip Grant, Soo‐Yon Rhee, Suzanne M. McCluskey, Michael R. Jordan, Rebecca L. Morgan, Robert W. Shafer - Viruses 2024 cited by 55

  18. Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review

    Authors: Kaiming Tao, Soo‐Yon Rhee, Carolyn Chu, Ava Avalos, Amrit Ahluwalia, Ravindra K. Gupta, Michael R. Jordan, Robert W. Shafer - Viruses 2023 cited by 51

  19. Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

    Authors: Diane Bennett, Ricardo Camacho, Dan Oţelea, Daniel R. Kuritzkes, Hervé Fleury, Mark Kiuchi, Walid Heneine, Rami Kantor, Michael R. Jordan, Jonathan Schapiro, Anne–Mieke Vandamme, Paul Sandstrom, Charles A. Boucher, David van de Vijver, Soo‐Yon Rhee, Tommy F. Liu, Deenan Pillay, Robert W. Shafer - PLoS ONE 2009 cited by 960

  20. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    Authors: John Gregson, Michele W. Tang, Nicaise Ndembi, Raph L Hamers, Soo‐Yon Rhee, Vincent C. Marconi, Lameck Diero, Katherine Brooks, Kristof Theys, Tobias Rinke de Wit, Mônica Barcellos Arruda, Fréderico Duarte Garcia, Susana Monge, Huldrych F. Günthard, Christopher J. Hoffmann, Phyllis J. Kanki, N. Kumarasamy, Bernard Kerschberger, Orna Mor, Charlotte Charpentier, Eva Todesco, Casper Rokx, Luuk Gras, Elias K Helvas, Henry Sunpath, Domenico Di Carlo, Antonio Antinori, Massimo Andreoni, Alessandra Latini, Cristina Mussini, Avelin F. Aghokeng, Anders Sönnerborg, Ujjwal Neogi, W. Jeffrey Fessel, Simon Agolory, Chunfu Yang, José Luís Blanco, James Juma, Erasmus Smit, Daniel Schmidt, Christine Watera, Juliet Asio, Wilford Kurungi, Anna Tostevin, Tal El‐Hay, Nathan Clumeck, Dominique Goedhals, Cloete van Vuuren, Philip Armand Bester, Caroline Sabin, Irene Mukui, Maria Mercedes Santoro, Carlo Federico Perno, Gillian Hunt, Lynn Morris, Ricardo Camacho, Túlio de Oliveira, Deenan Pillay, Eugene Schulter, Akio Murakami-Ogasawara, Gustavo Reyes‐Terán, Karla Romero, Santiago Ávila‐Ríos, Sunee Sirivichayakul, Kiat Ruxrungtham, Suwanna Mekprasan, David Dunn, Pontiano Kaleebu, Elliot Raizes, Rami Kantor, Robert W. Shafer, Ravindra K. Gupta - The Lancet Infectious Diseases 2016 cited by 275

  21. HIV-1 Antiretroviral Resistance

    Authors: Michele W. Tang, Robert W. Shafer - Drugs 2012 cited by 324

  22. Emerging SARS-CoV-2 Resistance After Antiviral Treatment

    Authors: Trevor J. Tamura, Manish C. Choudhary, Rinki Deo, Fizah Yousuf, A. Gomez, Gregory E. Edelstein, Julie Boucau, Owen T. Glover, Mamadou Barry, Rebecca F. Gilbert, Zahra Reynolds, Yijia Li, Dessie Tien, Tammy D. Vyas, Eliza Passell, Karry Su, Sarah Drapkin, Emory Abar, Yumeko Kawano, Jeffrey A. Sparks, Zachary S. Wallace, Jatin M. Vyas, Robert W. Shafer, Mark J. Siedner, Amy K. Barczak, Jacob E. Lemieux, Jonathan Z. Li, POSITIVES Study Team - JAMA Network Open 2024 cited by 42

  23. Combating antimicrobial resistance in malaria, HIV and tuberculosis

    Authors: Maëlle Duffey, Robert W. Shafer, Juliano Timm, Jeremy N. Burrows, Nader Fotouhi, Mark I. Cockett, Didier Leroy - Nature Reviews Drug Discovery 2024 cited by 34

  24. Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1

    Authors: Robert W. Shafer, Dominique A. Vuitton - Biomedicine & Pharmacotherapy 1999 cited by 150